Review



allogeneic t cells expressing anti-cd22 car  (Cellectis sa)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cellectis sa allogeneic t cells expressing anti-cd22 car
    Current allogeneic cell therapies in clinical trials.
    Allogeneic T Cells Expressing Anti Cd22 Car, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/allogeneic+t+cells+expressing+anti-cd22+car/anti+cd22+car++anti+cd22+scfv+41bb+cd3%CE%B6/pmc09100203-7-18-31
    Average 90 stars, based on 1 article reviews
    allogeneic t cells expressing anti-cd22 car - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy"

    Article Title: Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy

    Journal: Cancers

    doi: 10.3390/cancers14092266

    Current allogeneic cell therapies in clinical trials.
    Figure Legend Snippet: Current allogeneic cell therapies in clinical trials.

    Techniques Used: Bioprocessing, Expressing, Activity Assay

    Related Articles

    Expressing:

    Article Title: Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
    Article Snippet: NCT03190278 , Study evaluating safety and efficacy of UCART123 , Allogeneic T-cells expressing anti-CD123 CAR , Relapsed/refractory acute myeloid leukemia (AML) , Cellectis. .. NCAT041500497 , Phase 1 study of UCART22 in patients with R/R CD22+ BALL , Allogeneic T cells expressing anti-CD22 CAR , Relapsed or refractory CD22 + B-cell acute lymphoblastic leukemia , Cellectis. .. NCT04142619 , Study evaluating safety of and efficacy of UCART targeting CS1 in patients with R/R MM , Allogeneic T cells expressing anti-CS1 CAR , Relapsed/refractory MM , Cellectis.



    Similar Products

    allogeneic t cells expressing anti-cd22 car  (Cellectis sa)
    90
    Cellectis sa allogeneic t cells expressing anti-cd22 car
    Current allogeneic cell therapies in clinical trials.
    Allogeneic T Cells Expressing Anti Cd22 Car, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/allogeneic+t+cells+expressing+anti-cd22+car/anti+cd22+car++anti+cd22+scfv+41bb+cd3%CE%B6/pmc09100203-7-18-31
    Average 90 stars, based on 1 article reviews
    allogeneic t cells expressing anti-cd22 car - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Current allogeneic cell therapies in clinical trials.

    Journal: Cancers

    Article Title: Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy

    doi: 10.3390/cancers14092266

    Figure Lengend Snippet: Current allogeneic cell therapies in clinical trials.

    Article Snippet: NCAT041500497 , Phase 1 study of UCART22 in patients with R/R CD22+ BALL , Allogeneic T cells expressing anti-CD22 CAR , Relapsed or refractory CD22 + B-cell acute lymphoblastic leukemia , Cellectis.

    Techniques: Bioprocessing, Expressing, Activity Assay